Heart Lung Machine Registry

Study Overview
=================
Brief Summary
-----------------
The HeaLMe post-market clinical follow-up registry is undertaken to evaluate the safety and performance of the index devices Heart Lung Machine HL 40 and Temperature Probes TPO-D-HLM L1.8 Adult / Pediatric in patients undergoing cardiac / thoracic / vascular surgery.

Detailed Description
-----------------
In this study, patients who are connected to the index devices Heart Lung Machine HL 40 and Temperature Probes TPO-D-HLM L1.8 Adult / Pediatric and undergo a cardiac / thoracic / vascular surgery will be observed. This includes neonates, infants, adolescents and adults regardless of age and underlying health condition. It also includes elective, urgent and emergent surgeries. Data will be collected for each participant according to the study schedule and standard routine clinical practice at the enrolling centers. There will be no additional visits, nor procedures pertaining to the study itself for subjects who participate in the study. Informed consent of the patients will be obtained to allow the use of their clinical records for the purpose of this observational study before data are being collected. The period of data collection for each patient will be only the index procedure. The index procedure is defined as the investigator's planned initial procedure in which the patient is connected to the HL 40 and the Temperature Probes. The index procedure starts with the cannulation of the patient for the index procedure and ends with the de-cannulation of the patient.

Official Title
-----------------
Post-Market Clinical Follow-up Registry to Evaluate the Safety and Performance of the HL 40 Heart Lung Machine and the Temperature Probes in Patients Undergoing Cardiac / Thoracic / Vascular Surgery

Conditions
-----------------
Cardiac Surgery, Thoracic Surgery, Vascular Surgery, Cardiopulmonary Bypass

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Signed Patient Informed Consent (including emergency approach) All patients who are connected to extracorporeal circulation using the index devices. Exclusion Criteria: Pregnancy Current participation or planned participation in a concurrent drug or interventional medical device study
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Performance Endpoint | The rate of cases performed by the index devices during the index procedure without any failure and / or malfunction related to the index device(s). | Only during the index procedure, no FU. | 
| Safety Endpoint | The rate of index device(s) related Adverse Events during the index procedure. | Only during the index procedure, no FU. | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Heart Lung Machine, HL 40, Temperature Probes, TPO-D-HLM L1.8 Adult, TPO-D-HLM L1.8 Pediatric